Furthermore, we found that there was an interaction between SLC47A1 rs2289669 and SLC22A1 rs594709, which affected the blood glucose, insulin level, insulin resistance improvement, and blood lipid after metformin treatment. The gene discussed is SLC22A1; the disease is Insulin resistance.